Diverse clinical manifestations of Parvovirus B19 infections during the 2024 outbreak in Germany
This resurgence in symptomatic PB19V infections, likely driven by pandemic-related shifts in immunity and exposure, underscores the need for heightened clinical awareness, early testing in high-risk populations, and sustained surveillance to anticipate future outbreaks.
Authors
- Alessandra Holzem (ORCID: https://orcid.org/0000-0002-3241-3446)
- Henning Gruell (ORCID: https://orcid.org/0000-0002-0725-7138)
- Karsten Spiekermann (ORCID: https://orcid.org/0000-0002-5139-4957)
- Michael von Bergwelt‐Baildon (ORCID: https://orcid.org/0000-0002-1952-052X)
- Enrico Schalk (ORCID: https://orcid.org/0000-0003-1892-5098)
- Tilmann Schober (ORCID: https://orcid.org/0000-0002-9440-3761)
- Antonia Zeuzem
- Jannik Stemler (ORCID: https://orcid.org/0000-0001-9152-2469)
- Christine E. Deppe
- J Hübner
- Susan Bohm
Institutions
- University of Cologne (DE)
- LMU Klinikum (DE)
- Düsseldorf University Hospital (DE)
- Integrated Oncology (United States) (US)
- Department of Virology (FR)
- German Center for Infection Research (DE)
- University Children's Hospital Tübingen (DE)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
- Ludwig-Maximilians-Universität München (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Infection
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1007/s15010-025-02598-6
- Citations
- 4
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.58
Funders
- Otto von Guericke University Magdeburg